Current approaches to neoadjuvant immunotherapy in resectable non-small cell lung cancer
J Parekh, K Parikh, JE Reuss, A Friedlaender… - Current oncology …, 2023 - Springer
Abstract Purpose of Review For decades, early-stage resectable non-small cell lung cancer
(NSCLC), while potentially curable, has been marred by unacceptably high recurrence …
(NSCLC), while potentially curable, has been marred by unacceptably high recurrence …
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
Pathological complete response (pCR) after neoadjuvant chemotherapy (NCT) is associated
with good long-term prognosis in breast cancer (BC) patients. However, some patients still …
with good long-term prognosis in breast cancer (BC) patients. However, some patients still …
[HTML][HTML] Intercontinental Comparison of Immunohistochemical Subtypes Among Individuals With Breast Cancer in South-East Asia and South America: A Scoping …
D Hermansyah, NN Firsty, RHN Siagian… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Background Breast cancer (BC) remains a significant global concern, particularly among
developing countries in South-East Asia (SEA) and South America (SA). The socioeconomic …
developing countries in South-East Asia (SEA) and South America (SA). The socioeconomic …
[HTML][HTML] Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete …
M Antonini, A Mattar, FGB Richter, GD Pannain… - The Breast, 2023 - Elsevier
Objectives We aimed to evaluate the pCR rate in patients receiving NAC for the treatment of
breast cancer (BC) in a multicenter cohort in Brazil. Additionally, we aimed to use RWD to …
breast cancer (BC) in a multicenter cohort in Brazil. Additionally, we aimed to use RWD to …
[HTML][HTML] Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center
M Antonini, A Mattar, FGB Richter… - Chinese Clinical …, 2024 - cco.amegroups.org
Background: Neoadjuvant chemotherapy (NAC), traditionally used for locally advanced
disease, is now applied for operable disease, particularly to treat aggressive breast cancer …
disease, is now applied for operable disease, particularly to treat aggressive breast cancer …
[HTML][HTML] Aktuelle Ansätze zur neoadjuvanten Immuntherapie des resektablen nicht kleinzelligen Lungenkarzinoms
J Parekh, K Parikh, JE Reuss, A Friedlaender… - Kompass …, 2023 - karger.com
Zweck der Übersichtsarbeit: Seit Jahrzehnten ist das nicht kleinzellige Lungenkarzinom
(non-small cell lung cancer, NSCLC) im Frühstadium potenziell heilbar, weist aber eine …
(non-small cell lung cancer, NSCLC) im Frühstadium potenziell heilbar, weist aber eine …